Molecular Pathology of Cartilage destruction in Rheumatoid Arthritis

类风湿关节炎软骨破坏的分子病理学

基本信息

  • 批准号:
    10470051
  • 负责人:
  • 金额:
    $ 8.13万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Degradation of the extracellular matrix (ECM) is an essential step to the destruction of articular cartilage in rheumatoid athritis (RA), and members of the matrix metalloproteinase (MMP) gene family are involved in the degradation. In the present studies, we characterized the biochemical properties of some MMP species and examined their functions in the destruction of the cartilage in RA joints. In addition, synthetic MMP inhibitors and tissue inhibitor of metalloproteinases 3 (TIMP-3)-inducible drug were developed by collaboration with pharmaceutical companies. The major results are as follows:(1). Activation of proMMP-2 mediated by membrane-type1 MMP (MT1-MMP) was accelerated in the presence of TIMP-2, and thus TIMP-2 was considered to be essential to the efficient activation of proMMP-2 on the cell membranes. We also demonstrated that MT1-MMP cleaves aggrecan at three sites in the interglobular domain and MT3-MMP degrades the ECM components such as type III collagen and aggrecan. O … More n the other hand, the activities of MT1-MMP and MT3-MMP were not inhibited by TIMP-1. MT-MMP was shown to be shed from the cell membranes of tumor cells treated with concanvalin A.(2). ProMMP-2 was efficiently activated in RA synovial tissues and its activation ratio directly correlated with the expression levels of MT1-MMP among MT1, 2, 3-MMPs. MT1-MMP was expressed in the lining cells of RA synovial membrane and gelatinolytic activity was detected by in situ zymography in the lining cell layer.(3). When steady state levels of MMP-1, 2, 3, 7, 8, 9, 13 and TIMP-1, 2 in synovial fluids were assayed by sandwich enzyme immunoassays, the levels of MMP 1, 2, 3, 8, 9 and TIMP-1 were significantly higher in RA than in OA. The molar ratio was significantly higher in RA than in OA, and metalloproteinase activity was detected with a direct correlation to MMP/TIMP molar ratio, suggesting an imbalance in favor of proteinase.(4). By collaboration with a pharmaceutical company, we developed synthetic inhibitors more selective to MT1-MMP, We also demonstrated that pentosan polysulfate stimulates RA synovial fibroblasts to produce TIMP-3 by the posttranscriptional level. Less
细胞外基质(ECM)的降解是类风湿性关节炎(RA)关节软骨破坏的重要步骤,基质金属蛋白酶(MMP)基因家族的成员参与了降解。在本研究中,我们表征了一些 MMP 物种的生化特性,并检查了它们在破坏 RA 关节软骨中的功能。此外,还与制药公司合作开发了合成MMP抑制剂和金属蛋白酶3(TIMP-3)诱导药物的组织抑制剂。主要研究结果如下: (1). TIMP-2 存在时,膜型 1 MMP (MT1-MMP) 介导的 proMMP-2 的激活会加速,因此 TIMP-2 被认为对于细胞膜上 proMMP-2 的有效激活至关重要。我们还证明 MT1-MMP 在球间结构域的三个位点裂解聚集蛋白聚糖,MT3-MMP 降解 ECM 成分,如 III 型胶原和聚集蛋白聚糖。另一方面,MT1-MMP 和 MT3-MMP 的活性不受 TIMP-1 的抑制。经伴刀豆球蛋白 A 处理的肿瘤细胞的细胞膜显示 MT-MMP 脱落。(2)。 ProMMP-2在RA滑膜组织中被有效激活,其激活率与MT1、2、3-MMP中MT1-MMP的表达水平直接相关。 MT1-MMP在RA滑膜衬里细胞中表达,并通过原位酶谱法检测衬里细胞层的明胶分解活性。(3).当通过夹心酶免疫分析法测定滑液中MMP-1、2、3、7、8、9、13和TIMP-1、2的稳态水平时,RA中MMP-1、2、3、8、9和TIMP-1的水平显着高于OA。 RA 中的摩尔比显着高于 OA,并且检测到的金属蛋白酶活性与 MMP/TIMP 摩尔比直接相关,表明存在有利于蛋白酶的不平衡。(4)。通过与制药公司合作,我们开发了对 MT1-MMP 更具选择性的合成抑制剂,我们还证明多硫酸戊聚糖可刺激 RA 滑膜成纤维细胞在转录后水平产生 TIMP-3。较少的

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohta S.: "Expression of matrix metalloproteinase 7(matrilysin) in human osteoarthritic cartilage"Lab. Invent. 78. 79-87 (1998)
Ohta S.:“基质金属蛋白酶 7(基质溶解素)在人骨关节炎软骨中的表达”实验室。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Oshita T.: "TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads"J. Biol. Chem.. 273. 16098-16103 (1998)
Oshita T.:“TIMP-2 通过固定在琼脂糖珠上的膜型 1 基质金属蛋白酶促进原明胶酶 A 的活化”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimada T.: "Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase"Eur. J. Biochem.. 262. 907-914 (1999)
Shimada T.:“人膜3型基质金属蛋白酶的截短重组形式的表征”Eur。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimada T.: "Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase"Euro. J. Biochem. 262. 907-914 (1999)
Shimada T.:“人膜3型基质金属蛋白酶的截短重组形式的表征”Euro。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okada Y.: "In Textbook of Rheumatology. Ed. by Kelley W. N., Harris E.D., Jr. Ruddy S. and Sledge C. B. 6th edition, W. B. Saunders Company. Philadelphia, pp"Proteinases and matrix degradation. (in press). (2000)
Okada Y.:“《风湿病学教科书》。作者:Kelley W. N.、Harris E.D.、Jr. Ruddy S. 和 Sledge C. B. 第 6 版,W. B. Saunders Company。费城,页”蛋白酶和基质降解。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKADA Yasunori其他文献

OKADA Yasunori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKADA Yasunori', 18)}}的其他基金

Pathological study on metalloproteinases in tissue remodeling under pathological conditions
病理条件下金属蛋白酶参与组织重塑的病理学研究
  • 批准号:
    24249022
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study of integral transformations in hyperfunctions and differential operators of infinite order
超函数积分变换和无限阶微分算子的研究
  • 批准号:
    22540173
  • 财政年份:
    2010
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analyses and regulation of the metabolism of tissue microenvironmental factors by metalloproteinases
金属蛋白酶对组织微环境因子代谢的功能分析和调节
  • 批准号:
    19109004
  • 财政年份:
    2007
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Pathological studies on the tissue destruction by metalloproteinases
金属蛋白酶组织破坏的病理学研究
  • 批准号:
    16209015
  • 财政年份:
    2004
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study of global solutions to Fuchsian equations and local solutions to linear PDE
Fuchsian方程全局解和线性偏微分方程局部解的研究
  • 批准号:
    15540156
  • 财政年份:
    2003
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research concerning Privacy Protection Principles about Data Transfer from EU to the United States
欧盟至美国数据传输隐私保护原则研究
  • 批准号:
    14520022
  • 财政年份:
    2002
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of MT1-MMP gene expression by HMGI-C
HMGI-C对MT1-MMP基因表达的调控
  • 批准号:
    11694311
  • 财政年份:
    1999
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analyzes on ECM metabolism in transgenic and knockout mice
转基因和基因敲除小鼠 ECM 代谢分析
  • 批准号:
    08044262
  • 财政年份:
    1996
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Studies on the destruction of articular cartilage by matrix metalloproteinases
基质金属蛋白酶破坏关节软骨的研究
  • 批准号:
    07457049
  • 财政年份:
    1995
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Developing new tests and treatments to enable prevention of osteoarthritis.
开发新的测试和治疗方法以预防骨关节炎。
  • 批准号:
    MR/Y003470/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Fellowship
Repurposing Alpha-1-antitrypsin as a treatment for post-traumatic osteoarthritis
重新利用 Alpha-1-抗胰蛋白酶治疗创伤后骨关节炎
  • 批准号:
    MR/Y013883/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Research Grant
Contribution of synovial fibroblast cell subsets to the pathogenesis of knee osteoarthritis
滑膜成纤维细胞亚群对膝骨关节炎发病机制的贡献
  • 批准号:
    479219
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Operating Grants
Does BMI miss the mark? Use of an abdominal obesity index in osteoarthritis
BMI 是否达标?
  • 批准号:
    499189
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Operating Grants
Pathophysiology of osteoarthritis focusing on transcriptional enhancers from GWAS and single cell RNAseq analysis
骨关节炎的病理生理学重点关注 GWAS 和单细胞 RNAseq 分析中的转录增强子
  • 批准号:
    23K08697
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developing a gait-based system to detect early knee osteoarthritis.
开发基于步态的系统来检测早期膝骨关节炎。
  • 批准号:
    23K16633
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A machine learning model to assess the presence and severity of knee osteoarthritis based on gait data features
基于步态数据特征评估膝骨关节炎的存在和严重程度的机器学习模型
  • 批准号:
    23K16611
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The development of novel disease-modifying osteoarthritis drug candidate targeting supersulphides
针对超硫化物的新型缓解骨关节炎候选药物的开发
  • 批准号:
    23K19677
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of Drugs for Temporomandibular Joint Osteoarthritis Using Dental Pulp Stem Cells
利用牙髓干细胞开发治疗颞下颌关节骨关节炎的药物
  • 批准号:
    23K19746
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
  • 批准号:
    10641225
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了